Literature DB >> 25633929

A new method for scoring financial conflicts of interest.

S V M Maharaj.   

Abstract

BACKGROUND: There is a large and consistent body of evidence showing that research sponsored by for-profit industries tends to have pro-industry conclusions in comparison with similar research or re-analyses not funded by industry. Disclosure of financial conflicts via statements is presently the standard method for notification of potential biases. However, many journals are not consistent in publishing financial conflicts of interest (FCoI) statements. Furthermore, even when divulged, disclosure merely shifts the burden of evaluating conflicts to readers and the general public. Moreover, there has been an absence of a means of quantifying FCoI.
OBJECTIVES: To propose a solution for the question: What are we doing about FCoI that continue to compromise the integrity of the scientific enterprise?
METHODS: The FCoI Scale was developed for scoring and comparing FCoI and describing potential biases.
RESULTS: The FCoI Scale consists of a score that may be expressed in whole numbers and decimal fractions, correlated to descriptive terms for potential biases and examples of financial conflicts at 11 levels.
CONCLUSIONS: The FCoI score (FCoIS) provides a means for a more uniform and concise method of disclosure compared to statements, while at the same time permitting flexibility. It encourages the disclosure of relevant information and transparency in the reporting of financial conflicts. The FCoI Scale has the potential to become the standard basis for measuring, reporting, and comparing financial conflicts, suitable for disciplines in science, medicine, and beyond.

Keywords:  Campaign contributions,; Ethics,; FCoIS,; Industry or corporate funding,; Instrument or scale,; International organizations,; Public health and policy,; Scientific and medical journals and publishing,; Scientific societies and professional associations

Mesh:

Year:  2015        PMID: 25633929      PMCID: PMC4273519          DOI: 10.1179/2049396714Y.0000000097

Source DB:  PubMed          Journal:  Int J Occup Environ Health        ISSN: 1077-3525


  16 in total

1.  The uncertainty principle and industry-sponsored research.

Authors:  B Djulbegovic; M Lacevic; A Cantor; K K Fields; C L Bennett; J R Adams; N M Kuderer; G H Lyman
Journal:  Lancet       Date:  2000-08-19       Impact factor: 79.321

Review 2.  Pharmaceutical industry sponsorship and research outcome and quality: systematic review.

Authors:  Joel Lexchin; Lisa A Bero; Benjamin Djulbegovic; Otavio Clark
Journal:  BMJ       Date:  2003-05-31

3.  Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

Authors:  Bodil Als-Nielsen; Wendong Chen; Christian Gluud; Lise L Kjaergard
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

4.  Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.

Authors:  Mohit Bhandari; Jason W Busse; Dianne Jackowski; Victor M Montori; Holger Schünemann; Sheila Sprague; Derek Mears; Emil H Schemitsch; Dianne Heels-Ansdell; P J Devereaux
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

5.  Lifting the veil of secrecy from industry funding of nonprofit health organizations.

Authors:  Michael F Jacobson
Journal:  Int J Occup Environ Health       Date:  2005 Oct-Dec

Review 6.  Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Authors:  Anders W Jørgensen; Jørgen Hilden; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-10-06

7.  Industry influence on occupational and environmental public health.

Authors:  James Huff
Journal:  Int J Occup Environ Health       Date:  2007 Jan-Mar

8.  Manipulated data in Shell's Benzene Historical Exposure Study.

Authors:  David Egilman; Lerin Kol; Lea Anne Hegg; Susanna Rankin Bohme
Journal:  Int J Occup Environ Health       Date:  2007 Apr-Jun

Review 9.  Source of funding and results of studies of health effects of mobile phone use: systematic review of experimental studies.

Authors:  Anke Huss; Matthias Egger; Kerstin Hug; Karin Huwiler-Müntener; Martin Röösli
Journal:  Environ Health Perspect       Date:  2007-01       Impact factor: 9.031

10.  Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others.

Authors:  Lisa Bero; Fieke Oostvogel; Peter Bacchetti; Kirby Lee
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

View more
  3 in total

1.  Requirements of Clinical Journals for Authors' Disclosure of Financial and Non-Financial Conflicts of Interest: A Cross Sectional Study.

Authors:  Khaled Shawwa; Romy Kallas; Serge Koujanian; Arnav Agarwal; Ignacio Neumann; Paul Alexander; Kari A O Tikkinen; Gordon Guyatt; Elie A Akl
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

2.  Authorship, plagiarism and conflict of interest: views and practices from low/middle-income country health researchers.

Authors:  Anke Rohwer; Taryn Young; Elizabeth Wager; Paul Garner
Journal:  BMJ Open       Date:  2017-11-22       Impact factor: 2.692

3.  Reporting of financial and non-financial conflicts of interest by authors of systematic reviews: a methodological survey.

Authors:  Maram B Hakoum; Sirine Anouti; Mounir Al-Gibbawi; Elias A Abou-Jaoude; Divina Justina Hasbani; Luciane Cruz Lopes; Arnav Agarwal; Gordon Guyatt; Elie A Akl
Journal:  BMJ Open       Date:  2016-08-10       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.